Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127619001 | 12761900 | 1 | I | 20160722 | 0 | 20160915 | 20160915 | DIR | FDA-CTU | 0.00 | M | N | 0.00000 | 20160825 | N | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127619001 | 12761900 | 1 | PS | IMATINIB MESYLATE. | IMATINIB MESYLATE | 1 | Oral | 1 TABLET (400MG) ONCE DAILY BY MOUTH | 0 | 400 | MG | COATED TABLET | QD | ||||||
| 127619001 | 12761900 | 2 | SS | IMATINIB MESYLATE. | IMATINIB MESYLATE | 1 | Oral | 3 TABLETS (300MG) ONCE DAILY BY MOUTH | 0 | 300 | MG | COATED TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127619001 | 12761900 | 1 | Acute lymphocytic leukaemia |
| 127619001 | 12761900 | 2 | Acute lymphocytic leukaemia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127619001 | 12761900 | Hepatic enzyme increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 127619001 | 12761900 | HP |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127619001 | 12761900 | 1 | 20160219 | 20160722 | 0 | |
| 127619001 | 12761900 | 2 | 20160219 | 20160722 | 0 |